Actinic Keratosis- Epidemiology Insights to 2023

 Published On: Apr, 2017 |    No of Pages: 40 |  Published By: DelveInsight | Format: PDF
Request Free Sample
DelveInsight’s “Actinic Keratosis - Epidemiology Insights, 2023” report provides an overview of the disease of the Actinic Keratosis for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Actinic Keratosis from 2013-2023.

Actinic Keratosis (AK) commonly known as a solar keratosis is a precancerous crusty lesion caused by damage from exposure to ultraviolet (UV) radiation. It is considered a pre-cancer condition if left untreated could develop into a skin cancer, most often squamous cell carcinoma (SCC). AKs appear on areas which are most commonly exposed to sun such as the face, scalp, shoulders, neck, the back of the hands and forearms, etc.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

The report provides historical as well as forecasted epidemiology of Actinic Keratosis in the 7MM.

Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Report Introduction
Overview
Signs and symptoms
Risk Factors
Pathophysiology
Diagnosis
Histopathology
Epidemiology and Patient Population
United States
Europe
Germany
France
United Kingdom
Italy
Spain
Japan
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables
Table 1: Prevalent and Treatable Population of Actinic Keratosis in United States (2013-2023)
Table 2: Prevalent and Treatable Population of Actinic Keratosis in Germany (2013-2023)
Table 3: Prevalent and Treatable Population of Actinic Keratosis in France (2013-2023)
Table 4: Prevalent and Treatable Population of Actinic Keratosis in United Kingdom (2013-2023)
Table 5: Prevalent and Treatable Population of Actinic Keratosis in Italy (2013-2023)
Table 6: Prevalent and Treatable Population of Actinic Keratosis in Spain (2013-2023)
Table 7: Prevalent and Treatable Population of Actinic Keratosis in Japan(2013-2023)

List of Figures
Figure 1: Prevalent and Treatable Population of Actinic Keratosis in United States (2013-2023)
Figure 2: Prevalent and Treatable Population of Actinic Keratosis in Germany (2013-2023)
Figure 3: Prevalent and Treatable Population of Actinic Keratosis in Italy (2013-2023)
Figure 4: Prevalent and Treatable Population of Actinic Keratosis in Spain (2013-2023)
Figure 5: Prevalent and Treatable Population of Actinic Keratosis in France (2013-2023)
Figure 6: Prevalent and Treatable Population of Actinic Keratosis in United Kingdom (2013-2023)
Figure 7: Prevalent and Treatable Population of Actinic Keratosis in Japan (2013-2023)
Figure 8: IngenolDisoxate, Clinical Trials by Zone, 2017
Figure 9:Clinical Trials by Recruitment status, 2017
Figure 10: Number of Products under development by Companies, 2017
Figure 11: Clinical Stage Products, 2017
Figure 12: Pre-Clinical Stage Products, 2017
Figure 13: Assessment by Monotherapy Products, 2017
Figure 14: Assessment by Combination Products, 2017
Figure 15: Assessment by Route Of Administration, 2017
Figure 16: Assessment by Stage and Route Of Administration, 2017
Figure 17: Assessment by Molecule Type, 2017
Figure 18: Assessment by Stage and Molecule Type, 2017
Figure 19: Assessment by Stage of development and Domain, 2017
Figure 20: Assessment by Stage of development and Domain, 2017
Figure 21: Total Market size of Actinic Keratosis in USD Million (2013-2023)
Figure 22: United States Market Size of Actinic Keratosis in USD, Million (2013-2023)
Figure 23: Germany Market Size of Actinic Keratosis in USD, Million (2013-2023)
Figure 24: Italy Market Size of Actinic Keratosis in USD, Million (2013-2023)
Figure 25: Spain Market Size of Actinic Keratosis in USD, Million (2013-2023)
Figure 26: France Market Size of Actinic Keratosis in USD, Million (2013-2023)
Figure 27: United Kingdom Market Size of Actinic Keratosis in USD, Million (2013-2023)
Figure 28:Japan Market Size of Actinic Keratosis in USD, Million (2013-2023)

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.